Nitric oxide-still no consensus.
When NO became available for clinical use, it seemed to hold enormous promise for newborn infants with lung disease. With regard to the term and near-term infant, the role of NO seems satisfactorily defined: Near-term and term infants with hypoxic respiratory failure unresponsive to current therapy, excluding infants with diaphragmatic hernia, should have a trial of inhaled nitric oxide. In the preterm infant, the situation is less clear with, as yet, no specific indication identified.
Field
David J
DJ
Neonatal Intensive Care Unit, Leicester Royal Infirmary, Leicester LE1 5WW, UK. david.field@uhl-tr.nhs.uk
D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D009569:Nitric Oxide / Q000627:therapeutic use*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy*; D012131:Respiratory Insufficiency / Q000188:drug therapy*
D009569:Nitric Oxide